Live Breaking News & Updates on Roche Group Media

Stay updated with breaking news from Roche group media. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

F. Hoffmann-La Roche Ltd: Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above

Xofluza is now approved in the EU for the treatment of uncomplicated influenza and for post-exposure prophylaxis of influenza in children aged one year and above, and in adolescents and adultsXofluza is ....

United States , Baloxavir Marboxil , Levi Garraway , Sabine Borngr , Gerard Tobin , Bruno Eschli , Birgit Masjost , Loren Kalm , Nathalie Altermatt , Centers For Disease , Commission Decision , Shionogi Co Ltd , World Health Organization , European Commission , Head Of Global Product Development , Paediatr Child Health , Roche Group , Chief Medical Officer , Global Product , Dow Jones Sustainability Indices , Chugai Pharmaceutical , Infect Dis , Disease Control , Healthy Pediatric Participants From Birth , Roche Group Media ,

Investegate |F. Hoffmann-La Roche Ltd Announcements | F. Hoffmann-La Roche Ltd: Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older

Investegate announcements from F. Hoffmann-La Roche Ltd, Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older ....

United States , Pedro Piedra , Baloxavir Marboxil , Levi Garraway , Loren Kalm , Nathalie Altermatt , Roche Xofluza , Centers For Disease , Us Centers For Disease , Shionogi Co Ltd , European Commission , Drug Administration , Head Of Global Product Development , Roche Group , Baylor College Of Medicine , New Drug Application , Chief Medical Officer , Global Product , Disease Control , Molecular Virology , Baylor College , Pediatric Infectious Disease Journal , New England Journal , Dow Jones Sustainability Indices , Chugai Pharmaceutical , Preliminary In Season Burden ,

F. Hoffmann-La Roche Ltd: Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older

Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of age The FDA also approved Xofluza to prevent influenza ....

United States , Baloxavir Marboxil , Levi Garraway , Sabine Borngr , Roche Xofluza , Gerard Tobin , Bruno Eschli , Pedro Piedra , Birgit Masjost , Loren Kalm , Nathalie Altermatt , Centers For Disease , Us Centers For Disease , Shionogi Co Ltd , European Commission , Drug Administration , Head Of Global Product Development , Roche Group , Baylor College Of Medicine , New Drug Application , Chief Medical Officer , Global Product , Disease Control , Molecular Virology , Baylor College , Pediatric Infectious Disease Journal ,

Roche announces positive data from broad blood cancer portfolio at European Hematology Association Annual Meeting

10.06.2022 - Long-term data at the European Hematology Association (EHA) 2022 congress expands understanding of the impact of Roche medicines in early-stage blood cancers with the goal of providing patients with robust and durable outcomes from their first . ....

United States , Hong Kong , South Korea , Nathalie Meetz , Levi Garraway , Mabthera Rituxan , Gazyva Gazyvaro , Venclexta Venclyxto , Sileia Urech , Loren Kalm , Karsten Kleine , American Society Of Clinical Oncology , European Commission , European Hematology Association , Drug Administration , Head Of Global Product Development , European Medicines Agency , Roche Group , Roche Group Media Relations , Chief Medical Officer , Global Product , American Society , Clinical Oncology , Breakthrough Therapy Designations , Dow Jones , Sustainability Indices ,

F. Hoffmann-La Roche Ltd: Roche announces positive data from broad blood cancer portfolio at European Hematology Association Annual Meeting

Long-term data at the European Hematology Association (EHA) 2022 congress expands understanding of the impact of Roche medicines in early-stage blood cancers with the goal of providing patients with robust ....

United States , Hong Kong , South Korea , Nathalie Meetz , Levi Garraway , Mabthera Rituxan , Gazyva Gazyvaro , Sabine Borngr , Gerard Tobin , Bruno Eschli , Sileia Urech , Venclexta Venclyxto , Birgit Masjost , Loren Kalm , Karsten Kleine , American Society Of Clinical Oncology , European Commission , European Hematology Association , Drug Administration , Head Of Global Product Development , European Medicines Agency , Roche Group , Roche Group Media Relations , Chief Medical Officer , Global Product , American Society ,